suprofen (Profenal) Report issue

Small molecule Withdrawn
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Suprafen is a dual inhibitor of COX-1 and COX-2, which was used for the inhibition of intraoperative miosis. Suprafen was marketed under the name Profenal, however, it is no longer available in the USA.   NCATS

Chemistry

  • SMILES: CC(C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
  • InChIKey: MDKGKXOCJGEUJW-UHFFFAOYSA-N
  • Mol. Mass: 260.308
  • ALogP: 3.17
  • ChEMBL Molecule:
    suprofen  
More Chemistry

Pharmacology

Alternative names

2-(4-(2-thenoyl)phenyl)propionsaeure | 2-[4-(thiophene-2-carbonyl)-phenyl]-propionic acid | (+-)-2-(p-(2-thenoyl)phenyl)propionic acid | 4-(2-thenoyl)hydratropsaeure | alpha-methyl-4-(2-thienylcarbonyl)benzeneacetic acid | masterfen | p-2-thenoylhydratropic acid | profenal | profenol | r-25061 | racemic suprofen | suprofen | (+/-)-suprofen | suprofene | suprofène | suprofeno | suprofen rs | suprofenum | sutoprofen

Organizations (2)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Osteoarthritis (approved 1988)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue